Buy Hyperbaric Chamber Australia: Suppliers, Prices and Buying Guide

buy hyperbaric chamber australia

Affiliate Disclosure

This article contains affiliate links. If you purchase through these links, we may earn a commission at no additional cost to you. This does not influence our evaluations or rankings.


How we evaluate: Our recommendations are based on published clinical evidence, manufacturer specifications, and real user feedback. We may earn a commission if you purchase through our links, at no extra cost to you. This does not influence our rankings.
Full disclosure.

Buying a hyperbaric chamber in Australia requires navigating different regulations than the US market. Chambers in Australia are classified as wellness equipment rather than medical devices in most retail contexts, meaning the FDA 510(k) clearance framework that governs the US does not directly apply. This guide covers where to buy, what certifications matter in Australia, what you should pay, and which suppliers stand behind their products.

The Australian Regulatory Landscape

Australia’s regulatory framework for hyperbaric chambers differs from the US FDA system. The Therapeutic Goods Administration (TGA) is Australia’s equivalent of the FDA, but the regulatory pathway depends on how the chamber is marketed.

Chambers sold purely as wellness equipment without therapeutic claims fall outside TGA’s medical device framework in most cases. This is why many Australian retailers describe their chambers as “wellness equipment” rather than medical devices. Chambers making specific therapeutic claims for listed medical indications must be TGA registered, which is a significantly higher regulatory bar.

For clinical use in Australian hospitals, chambers must meet TGA requirements as well as state health department facility standards. Medicare coverage for HBOT in Australia requires treatment in a “comprehensive hyperbaric medicine facility” operating at 2.8 ATA or higher with mechanical ventilation capability.

Where to Buy a Hyperbaric Chamber in Australia

OxyRevo Australia (oxyrevo.com.au)

OxyRevo offers one of the most accessible paths to higher-pressure chambers in Australia. Their Apex series (soft shell, 1.5 ATA) and Quest/Space series (hard shell, 1.5–2.0 ATA) are available through the Australian distributor. CE certified. Not TGA registered as medical devices, but the hardshell models reach pressures above what most other Australian home chamber options provide.

iRestore (iRestore Salus36)

The iRestore delivers 1.35 ATA with carbon CO2 scrubbing technology, a useful feature that improves air quality during sessions. This represents a slight but meaningful pressure increase over the 1.3 ATA standard most soft chambers reach. Available through Australian distributors with local warranty support.

Tekna Manufacturing (Queensland, Australia)

Tekna builds Australian-made monoplace and multiplace clinical chambers. Their chambers are built for local regulatory compliance from the ground up and serve hospitals, research institutions, and major medical centers. If you are setting up a clinical facility in Australia, Tekna offers the advantage of local manufacturing, local support, and deep familiarity with Australian safety standards. Custom builds available to specification.

OxyHealth Australia

OxyHealth distributes their portable chamber range through Australian dealers. The Vitaeris 320 and Fortius series are available with local distributor support. OxyHealth has 28 years of manufacturing experience and has distributed over 18,000 chambers globally.[1] Australian distribution provides local warranty handling and support, a significant advantage over direct international purchase.

Perry Baromedical and Sechrist (via Australian Medical Equipment Importers)

Clinical-grade monoplace and multiplace chambers from Perry Baromedical and Sechrist Industries are available in Australia through authorized medical equipment importers. These are the same FDA-registered, ASME PVHO-1 certified chambers used in US hospitals. Expect significant lead times and costs, but the clinical standard matches what Australian hospitals require.

“Regulation is less strict in Australia than under the US FDA framework. No equivalent of FDA 510(k) clearance is required for wellness chamber sales. This means the due diligence burden falls more heavily on the buyer.”

Australian Chamber Pricing (2026)

Chamber Type Price Range (AUD) Pressure Certification
Soft shell (basic, Chinese import) $2,000–$5,000 1.3 ATA CE only
Soft shell (OxyHealth/Summit to Sea) $7,000–$15,000 1.3 ATA FDA cleared (US)
Soft shell (iRestore Salus36) $8,000–$14,000 1.35 ATA CE
Hard shell home (1.5–2.0 ATA) $20,000–$60,000 1.5–2.0 ATA CE
Clinical monoplace $80,000–$200,000+ 2.0–3.0 ATA TGA / ASME PVHO-1

Note: AUD pricing is approximate and subject to exchange rates, import duties, and freight costs. Direct imports from China add 10–25% for duties and $1,000–$3,000 for freight, often eroding apparent savings.

2.8 ATA
Minimum pressure required for Medicare-rebatable HBOT in a comprehensive Australian hyperbaric medicine facility. Most home chambers cannot qualify.

What to Verify Before Buying in Australia

The questions you should ask any Australian supplier before purchase:

  • Is this chamber registered with the TGA as a medical device, or sold only as wellness equipment?
  • What certification does the pressure vessel hold? (CE, ASME PVHO-1, or equivalent)
  • Where is the local service center and what is the warranty response time?
  • Are replacement parts (seals, compressor components, safety valves) stocked locally or imported?
  • Can the supplier provide references from Australian customers who have owned the chamber for 2+ years?

Avoid suppliers who cannot answer these questions, offer chambers dramatically below market prices, or ship from overseas with no local support structure. The risk profile of a poorly supported chamber in Australia is the same as anywhere: no parts, no service, and no recourse if something goes wrong.

Soft Shell vs Hard Shell in the Australian Market

Soft-shell chambers at 1.3 ATA deliver ambient air at slightly elevated pressure. At this pressure, the oxygen dose is modest. A 2023 study found tissue oxygenation at 1.4 ATA was approximately half the level achieved at 2.0 ATA.[2] For home wellness use this may be acceptable. For clinical applications, hard-shell chambers at 2.0+ ATA are the standard.

Australian buyers have more hard-shell options in the mid-price range than US buyers, partly because the regulatory framework is less restrictive. OxyRevo and similar brands offer 1.5–2.0 ATA hard-shell chambers at $20,000–$60,000 AUD that are not widely available in US authorized dealer channels due to the lack of FDA clearance.

Frequently Asked Questions

Do I need a prescription to buy a hyperbaric chamber in Australia?

No, for chambers sold as wellness equipment. TGA-registered medical devices may require a prescription or healthcare provider involvement. Most home chambers in Australia are sold as wellness products and do not require a prescription.

Is HBOT covered by Medicare in Australia?

Medicare covers HBOT for specific conditions including localized soft tissue radiation injuries and necrotizing soft tissue infections, when performed in a comprehensive hyperbaric medicine facility operating at 2.8 ATA or higher. Home chambers and most private clinics do not meet this standard.

Can I import a hyperbaric chamber from China directly to Australia?

Yes, but import duties (10–25%) and freight ($1,000–$3,000) typically erode much of the apparent savings. More importantly, you will have no local warranty support, no Australian service network, and limited recourse if the chamber is defective or fails.

References

  1. OxyHealth. Company Overview. oxyhealth.com; OxyRevo Australia. oxyrevo.com.au; HBOT Australia. hbotaustralia.au
  2. Sack RA et al. Transcutaneous oximetry in chronic ulcer patients at 1.4 ATA vs 2.0 ATA. Undersea & Hyperbaric Medicine. 2023. PMID: 38615347
  3. Therapeutic Goods Administration. Medical Devices. tga.gov.au
  4. Medicare Benefits Schedule. Hyperbaric Oxygen Therapy. mbsonline.gov.au

Medical Disclaimer

The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Seph Fontane Pennock

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website

Why Trust Our Evaluations

Our rankings are based on hands-on testing, published clinical data, and verified manufacturer specifications. We apply the same criteria to every product regardless of affiliate status. Editorial Process · Evaluation Methodology

Previous Article

The Cost of Hyperbaric Chamber by Macypanofficial: Ultimate Breakdown of 4 Investment Tiers

Next Article

Hyperbaric Chamber Manufacturers: 2026 Guide to 9 Industry-Leading Innovators

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

One Email a Week.
Better Health Decisions.

Weekly breakdowns of the latest HBOT, ozone therapy, and oxygen therapy research. Clinical insights, treatment protocols, and evidence-based guidance for patients and practitioners.
Trusted by patients, clinicians, and researchers worldwide